Clinical Trial Update: An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

View source ↗

Summary

An observational study evaluating the safety and effectiveness of Galantamine in patients with Alzheimer's disease over 18 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen-Cilag Pty Ltd | Conditions: Alzheimer Disease, Dementia | Status: COMPLETED